Literature DB >> 30245624

Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors.

Tatiana V Lipina1,2, Nikolay A Beregovoy3, Alina A Tkachenko1,2, Ekaterina S Petrova1,2, Marina V Starostina3, Qiang Zhou4, Shupeng Li4.   

Abstract

Both Disrupted-In-Schizophrenia-1 (DISC1) and dopamine receptors D2R have significant contributions to the pathogenesis of schizophrenia. Our previous study demonstrated that DISC1 binds to D2R and such protein-protein interaction is enhanced in patients with schizophrenia and Disc1-L100P mouse model of schizophrenia (Su et al., 2014). By uncoupling DISC1 × D2R interaction (trans-activator of transcription (TAT)-D2pep), the synthesized TAT-peptide elicited antipsychotic-like effects in pharmacological and genetic animal models, without motor side effects as tardive dyskinesia commonly seen with typical antipsychotic drugs (APDs), indicating that the potential of TAT-D2pep of becoming a new APD. Therefore, in the current study, we further explored the APD-associated capacities of TAT-D2pep. We found that TAT-D2pep corrected the disrupted latent inhibition (LI), as a hallmark of schizophrenia associated endophenotype, in Disc1-L100P mutant mice-a genetic model of schizophrenia, supporting further APD' capacity of TAT-D2pep. Moreover, we found that TAT-D2pep elicited nootropic effects in C57BL/6NCrl inbred mice, suggesting that TAT-D2pep acts as a cognitive enhancer, a desirable feature of APDs of the new generation. Namely, TAT-D2pep improved working memory in T-maze, and cognitive flexibility assessed by the LI paradigm, in C57BL/6N mice. Next, we assessed the impact of TAT-D2pep on hippocampal long-term plasticity (LTP) under basal conditions and upon stimulation of D2 receptors using quinpirole. We found comparable effects of TAT-D2pep and its control TAT-D2pep-scrambled peptide (TAT-D2pep-sc) under basal conditions. However, under stimulation of D2R by quinpirole, LTP was enhanced in hippocampal slices incubated with TAT-D2pep, supporting the notion that TAT-D2pep acts in a dopamine-dependent manner and acts as synaptic enhancer. Overall, our experiments demonstrated implication of DISC1 × D2R protein-protein interactions into mechanisms of cognitive and synaptic plasticity, which help to further understand molecular-cellular mechanisms of APD of the next generation.

Entities:  

Keywords:  D2R; DISC1; Disc1-L100P mouse model of schizophrenia; latent inhibition; synaptic plasticity

Year:  2018        PMID: 30245624      PMCID: PMC6137395          DOI: 10.3389/fnsyn.2018.00031

Source DB:  PubMed          Journal:  Front Synaptic Neurosci        ISSN: 1663-3563


  70 in total

Review 1.  The pharmacology of latent inhibition as an animal model of schizophrenia.

Authors:  P C Moser; J M Hitchcock; S Lister; P M Moran
Journal:  Brain Res Brain Res Rev       Date:  2000-09

Review 2.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

3.  Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway.

Authors:  Akinori Ishikawa; Tomoko Kadota; Ken Kadota; Hideki Matsumura; Shoji Nakamura
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

Review 4.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

5.  Clinical features of latent inhibition in schizophrenia.

Authors:  C Rascle; O Mazas; G Vaiva; M Tournant; O Raybois; M Goudemand; P Thomas
Journal:  Schizophr Res       Date:  2001-09-01       Impact factor: 4.939

Review 6.  Drug targets for cognitive enhancement in neuropsychiatric disorders.

Authors:  Tanya L Wallace; Theresa M Ballard; Bruno Pouzet; Wim J Riedel; Joseph G Wettstein
Journal:  Pharmacol Biochem Behav       Date:  2011-04-01       Impact factor: 3.533

7.  Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

Authors:  Xiaohua Li; Kelley M Rosborough; Ari B Friedman; Wawa Zhu; Kevin A Roth
Journal:  Int J Neuropsychopharmacol       Date:  2006-05-04       Impact factor: 5.176

8.  Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex.

Authors:  Myoung-Sun Roh; Myoung Suk Seo; Yeni Kim; Se Hyun Kim; Won Je Jeon; Yong Min Ahn; Ung Gu Kang; Yong Sung Juhnn; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2007-06-30       Impact factor: 8.718

9.  Attention to irrelevant cues is related to positive symptoms in schizophrenia.

Authors:  Richard Morris; Oren Griffiths; Michael E Le Pelley; Thomas W Weickert
Journal:  Schizophr Bull       Date:  2012-01-20       Impact factor: 9.306

10.  Copper Inhibits NMDA Receptor-Independent LTP and Modulates the Paired-Pulse Ratio after LTP in Mouse Hippocampal Slices.

Authors:  Nina L Salazar-Weber; Jeffrey P Smith
Journal:  Int J Alzheimers Dis       Date:  2011-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.